CapsoVision (CV) Income towards Parent Company (2024 - 2025)

CapsoVision (CV) reported Income towards Parent Company of -$7.4 million for Q4 2025, down 59.39% on a YoY basis from -$18.2 million in Q4 2024, and up 6.65% sequentially from -$7.9 million in Q3 2025.

CapsoVision (CV) Income towards Parent Company (2024 - 2025) Analysis & Trends

CapsoVision (CV) has 2 years of Income towards Parent Company data on file, last reported at -$7.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 59.39% year-over-year to -$7.4 million; the trailing twelve-month figure through Dec 2025 stood at -$24.6 million (changed N/A YoY), and the FY2025 full-year result was -$25.3 million, down 27.22% from the prior year.
  • Income towards Parent Company grew to -$7.4 million in Q4 2025, from -$7.9 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 CapsoVision 163.05 Mn 152.94 Mn 1.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.39 Mn
Sep 30, 2025 -7.92 Mn
Jun 30, 2025 -4.63 Mn
Dec 31, 2024 -4.64 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -5.27 Mn